^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    QL1206 (denosumab biosimilar)

    i
    Other names: QL1206
    Associations

    News

    Trials
    Company:
    Qilu Pharma
    Drug class:
    RANK ligand inhibitor
    Related drugs:
    Associations

    News

    Trials
    5ms
    A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® (clinicaltrials.gov)
    P3, N=278, Recruiting, Qilu Pharmaceutical Co., Ltd.
    New P3 trial
    |
    Prolia (denosumab) • QL1206 (denosumab biosimilar)